Revelation Biosciences, Inc.

Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in immune system therapeutics and diagnostics. The company's product pipeline includes REVTx-99b, a Phase Ib clinical trial candidate for chronic nasal congestion and allergic rhinitis; REVTx-200, a nonclinical stage intranasal therapy; REVTx-300, a potential therapy for chronic organ diseases; and REVDx-501, a rapid test kit for respiratory viral infections. These products are designed to address unmet medical needs and have the potential to generate revenue through commercialization and sales.

Products

• REVTx-99b

• REVTx-200

• REVTx-300

• REVDx-501